17-DMAG in Treating Patients With Metastatic or Unresectable Solid Tumors or Lymphomas
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
This phase I trial is studying the side effects and best dose of 17-DMAG in treating patients
with metastatic or unresectable solid tumors or lymphomas. Drugs used in chemotherapy, such
as 17-DMAG, work in different ways to stop cancer cells from dividing so they stop growing or
die